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Summary
Interleukin-1 receptor (IL-1RI) is a master regulator of
inflammation and innate immunity [1]. When triggered
by IL-1b, IL-1RI aggregates with IL-1R-associated pro-
tein (IL-1RAcP) and forms a membrane proximal sig-
nalosome that potently activates downstream signal-
ing cascades. IL-1b also rapidly triggers endocytosis
of IL-1RI [2, 3]. Although internalization of IL-1RI sig-
nificantly impacts signaling [4], very little is known
about trafficking of IL-1RI and therefore about pre-
cisely how endocytosis modulates the overall cellular
response to IL-1b. Upon internalization, activated re-
ceptors are often sorted through endosomes and de-
livered to lysosomes for degradation. This is a highly
regulated process that requires ubiquitination of
cargo proteins as well as protein-sorting complexes
that specifically recognize ubiquitinated cargo [5].
Here, we show that IL-1b induces ubiquitination of
IL-1RI and that via these attached ubiquitin groups,
IL-1RI interacts with the ubiquitin-binding protein
Tollip [6]. By using an assay to follow trafficking of
IL-1RI from the cell surface to late endosomes and ly-
sosomes, we demonstrate that Tollip is required for
sorting of IL-1RI at late endosomes. In Tollip-deficient
cells and cells expressing only mutated Tollip (incapa-
ble of binding IL-1RI and ubiquitin), IL-1RI accumu-
lates on late endosomes and is not efficiently de-
graded. Furthermore, we show that IL-1RI interacts
*Correspondence: kimburns@bluewin.ch
4 These authors contributed equally to this work.with Tom1, an ubiquitin-, clathrin-, and Tollip-binding
protein [7, 8], and that Tom1 knockdown also results
in the accumulation of IL-1RI at late endosomes. Our
findings suggest that Tollip functions as an endoso-
mal adaptor linking IL-1RI, via Tom1, to the endosomal
degradation machinery.
Results and Discussion
IL-1RI Is Ubiquitinated
IL-1RI is rapidly internalized, in an IL-1b-dependent
manner [4, 9], and slowly degraded [3, 10] (see also
Figure S1 in the Supplemental Data available online),
suggesting that it, like other receptors delivered to the
lysosomes for degradation, may be ubiquitinated. This
was addressed by immunoprecipitating IL-1RI from
a cell line stably expressing Flag-tagged IL-1RI (293-
Flag IL-1RI) before and after IL-1b stimulation with con-
ditions that exclude association of IL-1R-interacting
proteins (Figure 1). IL-1b treatment rapidly induced
IL-1RI ubiquitination, which remained so, albeit with di-
minishing intensity, over the duration of the time course
(4 hr) (Figure 1). The ladder-like pattern of ubiquitin spe-
cies conjugated to IL-1R were immunoreactive with
a ubiquitin antibody (P4D1) that recognizes monoubi-
quitin as efficiently as polyubiquitin but not with a sec-
ond antibody (FK1) that is specific for polyubiquitin
[11] (Figures S2A and S2B). This suggests that IL-1RI
may be conjugated by multiple monoubiquitin moieties,
as is the case for EGFR [11].
Tollip Is An Ub-Receptor for IL-1Rs
Ub-receptors are components of trafficking complexes
that have one or more ubiquitin-binding domains
(UBD) [12]. Tollip has a C-terminal UBD called the CUE
(coupling of ubiquitin to endoplasmic reticulum degra-
dation) domain [6, 13–15] that is crucial for its interaction
with IL-1Rs [14]. To determine whether this is because
Tollip acts as an Ub-receptor for ubiquitinated IL-1RI,
we transfected 293T cells with VSV-Tollip and Flag-
IL-1Rs (inducing both the expression of ubiquitinated
and nonubiquitinated forms) and then immunoprecipi-
tated VSV-Tollip. The VSV-Tollip immunoprecipitate
was probed with Flag antibodies, revealing that Tollip
only interacts with a higher-molecular-weight form of
the Flag-tagged receptor (Figure 2A, left panel). That
this was an ubiquitinated form of Flag-IL-1RI was con-
firmed in a second experiment in which it was dissoci-
ated from Tollip (by boiling in SDS), immunoprecipitated
with Flag antibodies, and subsequently immunoblotted
with anti-ubiquitin or Flag antibodies as indicated (Fig-
ure 2A, right panels). Tollip’s preference for ubiquiti-
nated IL-1RI correspondingly implied that Tollip’s ca-
pacity to bind ubiquitin was required for its interaction
with IL-1RI. To confirm this, we generated a form of
Tollip that was mutated at the MFP motif (residues
240–242 in the CUE domain), a high-affinity ubiquitin-
binding site common to several different CUE domains
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AA, rendered Tollip incapable of binding to endoge-
nously ubiquitinated proteins (Figure S3A). As
expected, coimmunoprecipitation of TollipMF/AA and
IL-1Rs was severely attenuated (Figures 2A and 2B);
however, interestingly, coimmunoprecipitation of Toll-
ipMF/AA and IRAK (a protein that is also ubiquitinated
after IL-1b stimulation and interacts with Tollip’s CUE
domain) was not affected (Figure 2C). In summary, these
results indicate that Tollip has the capacity to act as an
Ub-receptor for ubiquitinated IL-1RI.
Tollip Is Ubiquitinated via Its CUE Domain
Several Ub-receptors are themselves ubiquitinated,
a predictable consequence of their ability to bind di-
rectly to the activated intermediate of the ubiquitination
process [16]. It was thus not surprising to detect minor
forms (approximately 15 kDa higher) of Tollip but not
Figure 1. IL-1b Induces Ubiquitination of IL-1Rs
IL-1b rapidly induces ubiquitination of IL-1RI. 293-Flag-IL-1RI cells
were stimulated with IL-1b (20 ng/ml) for the indicated times and
then lysed in RIPA buffer. The Flag immunoprecipitates were probed
with antibodies against ubiquitin (Ub), P4D1, or Flag. The asterisk
denotes a band that is probably nonspecific in nature. As a control
for the stringency of immunoprecipitation, recruitment of Tollip,
IRAK, and MyD88 to the IL-1RI was examined and not detected.of TollipMF/AA (See Figure 2A). His-tagged Tollip was
immunoprecipitated under denaturing conditions (6 M
guanidine-HCL), used to exclude noncovalent associa-
tion of ubiquitin, and analyzed by 2D gel electrophoresis
revealing that Tollip (at least when overexpresssed) was
modified, in a CUE-domain-dependent manner, by con-
jugation of multiple ubiquitin moietes (Figures S4A and
S4B). The functional role of Tollip ubiquitination is pres-
ently unknown. However, it is tempting to speculate,
based on a recent report [17], that ubiquitination of Tollip
induces intramolecular interaction with its CUE domain
and thereby triggers release of Tollip from IL-1R. Be-
cause ubiquitinated Tollip is enriched by immunopre-
cipitation of IL-1R complex (see Figure 2A), it may also
promote the assembly of ubiquitin-linked protein net-
works important for sorting of IL-1RI [18].
Tollip Is Necessary for Sorting of IL-1RI at Late
Endosomes
IL-1RI is found at very low levels on the cell surface of
primary cell types precluding its detection. Therefore,
to follow IL-1RI trafficking and analyze Tollip’s role in
this process, we developed an assay by using wild-
type and Tollip-deficient mouse embryonic fibroblasts
(MEFs) [19] transfected with IL-1RI and IL-1RAcP.
Transfected IL-1RI localized to the plasma membrane
in both cell lines as revealed by immunostaining with
IL-1RI specific antibodies. Further endocytosis of cell-
surface IL-1RI was dependent on the addition of IL-1b
and thereby mimicked signal-dependent internalization
of endogenous receptors [2, 3] (Figure S5). Internaliza-
tion of IL-1RI occurred rapidly in both wild-type and
Tollip-deficient MEFs, indicating that Tollip is not crucial
for internalization per se (Figure 3A). To analyze whether
Tollip is subsequently required for trafficking of IL-1RI,
we monitored the localization of internalized IL-1RI after
different intervals of IL-1b stimulation by costaining it
with either early endosome antigen 1 (EEA1) orFigure 2. The Tollip-IL-1Rs Interaction Re-
quires Ubiquitin
(A) Tollip binds the ubiquitinated form of
IL-1Rs. 293T cells were cotransfected with
Flag-IL-1Rs (IL-1RI + IL-1RAcP) and VSV-
Tollip or VSV-TollipMF240/241 (TollipMF/AA).
Tollip/IL-1Rs complexes were immunopre-
cipitated with VSV antibody and either ana-
lyzed directly by western blotting with anti-
Flag and anti-VSV (left panel) or dissociated
by boiling in SDS and then subjected to a sec-
ond immunoprecipitation with Flag antibody
(right panel). The Flag immunoprecipitate
was then analyzed by western blotting with
anti-Ub and anti-Flag as indicated. The aster-
isk (*) indicates ubiquitinated Tollip. CE de-
notes cellular extract.
(B and C) TollipMF/AA binds IRAK but not
IL-1Rs. 293T cells were cotransfected with
Flag IL-1Rs, IRAK-1 D340N and VSV-Tollip,
or VSV-TollipMF240/241 (TollipMF/AA). The
Flag (B) or VSV (C) immunoprecipitates were
revealed with antibodies against IRAK-1,
Flag, or VSV as indicated.
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2267Figure 3. Sorting of IL-1RI at Late Endo-
somes Requires Tollip’s CUE Domain
(A) IL-1RI accumulates on late endosomes in
the absence of Tollip. 2/2 (Tollip-deficient)
or +/+ (wild-type) MEFs were transfected
with IL-1RI and IL-1RAcP then 24 hr later
were incubated with anti-IL-1RI (6B5) and
IL-1b (50 ng/ml) for 1 or 3 hr at 37C. Cells
were then permeabilized, incubated with sec-
ondary antibody against IL-1RI, and immuno-
stained for lysobisphosphatidic acid (LBPA).
Central sections imaged by confocal micros-
copy are shown. IL-1RI is shown in green;
LBPA is shown in red; and Draq 5 nuclear
staining is shown in blue.
(B) Tollip’s CUE domain mediates sorting of
IL-1RI at late endosomes. The left panel
shows cellular extracts that were prepared
from the following MEF cell lines: +/+ (wild-
type), 2/2 (Tollip deficient), +Tollip, +vector,
or +TollipMF/AA (Tollip-deficient MEFs sta-
bly reconstituted with the indicated vectors).
Equal amounts of protein were analyzed by
immunoblotting with Tollip antibodies. The
right panel shows trafficking of IL-1RI was
followed after 3 hr, as in (A) above. IL-1RI is
shown in green; Draq 5 nuclear staining is
shown in blue; and LBPA is shown in red. Co-
localization of IL-1RI and LBPA is shown in
the enlarged images.lysobisphosphatidic acid (LBPA), markers specific for
early and late endosomes, respectively (data not shown
and Figure 3A). Shortly after IL-1b stimulation (i.e., 30–60
min), the distribution of internalized IL-1RI was similar in
both wild-type and Tollip-deficient cells. Trafficking of
IL-1RI from early to late endosomes was also detected
in both cell types. However, after IL-1b stimulation for
longer periods (i.e., 3–6 hr) striking differences in the
levels of the IL-1RI were increasingly apparent in 2/2
and +/+ cells. In wild-type cells, IL-1RI became progres-
sively more difficult to detect, whereas in Tollip-deficient
cells, significant levels of IL-1RI remained, the majority
of which colocalized with LBPA (Figure 3A). IL-1RI
was therefore accumulating at late endosomes in
Tollip-deficient MEFs. This accumulation of IL-1RI could
be reversed by stable reconstitution of Tollip-deficient
cells with Tollip (+Tollip MEFs) but not with empty vector(+vector MEFs) or TollipMF/AA mutant (+TollipMF/AA
MEFs), indicating that Tollip and specifically its capacity
to act as an Ub-receptor for IL-1RI was required for effi-
cient sorting of IL-1RI at late endosomes (Figure 3B).
A Pool of Tollip Localizes to LBPA- and LAMP1-
Positive Vesicles
Consistent with a role in sorting IL-1RI at late endo-
somes, a significant pool of endogenous Tollip colocal-
ized with LBPA- and LAMP1- (late endosome and lyso-
some marker) positive vesicles (see Figures S6A–S6G
and S6Q–S6S). Because a small pool of Tollip was also
found on early endosomes (Figures S6H–S6M) and a sig-
nificant fraction was found in the cytosol (supported
by cellular fractionation), it is likely that the localization
of Tollip to late endosomes is a dynamic and highly
regulated process, controlled, at least in part, through
Current Biology
2268Figure 4. Tollip Facilitates Lysosomal Targeting of IL-1RI
(A) Degradation of IL-1RI is attenuated in the absence of Tollip. The indicated cell lines were transfected with IL-1RI and IL-1RAcP then 24 hr later
were incubated with IL-1RI (6B5) and IL-1b (50 ng/ml) for 6 hr at 37C in the presence or absence of leupeptin. Internalized IL-1RI was revealed as
described in Figure 3A. The mean fluorescent intensity (MFI) of IL-1RI-positive cells was calculated on >350 cells per condition in two separate
experiments. The data are represented as a percentage of the MFI in leupeptin-treated cells (100%) (+SE) for facilitation of direct comparison.
The asterisk (*) indicates a significant difference between +/+ and 2/2 cells, in the absence of leupeptin (*p < 0.005). A double asterisk (**) sig-
nifies a significant difference in MFI between wild-type cells with or without leupeptin (**p < 0.0001), indicating efficient IL-1RI degradation; how-
ever, this is not so in the case of 2/2 cells (p = 0.2).
(B) +/+ and2/2 cells were incubated overnight with 40 mg/ml rat IgGs in the presence or absence of 50 mg/ml leupeptin. Endocytosed IgGs were
revealed with rat antibodies, and cells were analyzed by confocal microscopy. The total number of labeled vesicles (containing IgGs) was
counted for each condition in 15 cells in three different experiments. Numbers were similar whether Tollip was present and are expressed as
a percentage of the total number of vesicles in leupeptin-treated cells (+SE) for facilitation of direct comparison.
(C) Recruitment of Tom1 to IL-1R abolishes Tollip interaction. 293T cells were cotransfected with Flag-IL-1Rs and VSV-Tom1 in the presence or
absence of VSV-Tollip. The Flag immunoprecipitates were revealed with antibodies against Flag or VSV as indicated. The asterisk (*) denotes the
IgG heavy chain.
(D) Tom1 knockdown results in accumulation of IL-1RI in LAMP1-positive vesicles. VSV-Tom1 (mouse) and VSV-Tollip were transfected in the
presence of increasing concentration of Tom1 siRNA or control siRNA. Lysates were prepared 24 hr later, and western-blot analysis was carried
out with a VSV antibody (upper panel). +/+ or2/2MEFs were transfected with Tom1 siRNA (50 nM) and after 24 hr, with IL-1RI and IL-1RAcP. The
cells were incubated with IL-1RI (6B5) antibody 24 hr later and with 50 ng/ml IL-1b for 6 hr at 37C. Cells were then permeabilized, incubated with
secondary antibody against the IL-1RI, and immunostained for LAMP1. Central sections imaged by confocal microscopy are shown. IL-1RI is
shown in green; LAMP1 is shown in red; and Draq 5 nuclear staining is shown in blue.
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2269Tollip’s internal C2 domain (a region that binds phos-
phatidylinositol-3-phosphate and phosphatidylinositol-
3,4,5-phosphate, phospholipids abundant on endocytic
vesicles) [20].
Tollip Is Required for Efficient Degradation of IL-1RI
Taken together, the above results suggested that Tollip
might be required for sorting of IL-1RI to lysosomes and
thereby facilitation of IL-1RI degradation. However, be-
cause of the low levels of IL-1RI (even in transfected
MEFs), it was not possible to obtain direct evidence
that this is the case by western-blot analysis. Therefore,
the content of internalized and immunolabeled IL-1RI in
transfected MEFs was measured by quantitative image
analysis. Cells treated with leupeptin to block degrada-
tion served to calibrate total receptor content
(Figure 4A). Strikingly, 6 hr after IL-1b stimulation, the
IL-1RI signal was significantly diminished in +/+ or
+Tollip MEFs but remained virtually unchanged in 2/2
as well as in +vector and + TollipMF/AA MEFs
(Figure 4A). The observed differences in the levels of im-
munolabeled IL-1RI were not the result of defective im-
munoglobulin degradation, which occurred with similar
efficiency in 2/2 and +/+ cells (Figure 4B). Tollip defi-
ciency also had no effect on transport of fluorescent
dextran, a soluble marker of bulk transport, to LBPA-
or LAMP1-positive vesicles (Figure S7A). Moreover,
EGFR (an ubiquitinated receptor sorted to lysosomes)
was degraded after EGF treatment with similar kinetics
in2/2 and +/+ MEFs (Figures S7B and S7C). Therefore,
Tollip and specifically its CUE domain were required for
efficient degradation of IL-1RI. Further, Tollip is not
a general Ub-receptor but has specificity for endocytic
cargo, which includes IL-1RI and conceivably other
ubiquitinated TIR-family receptors (i.e., TLR2, 4) with
which it interacts [13, 21]. Interestingly, Tollip interacts,
via its N terminus, with Tom1 and the related proteins,
Tom1L1 and L2, which are ubiquitin- and clathrin-bind-
ing proteins likely to be involved in the delivery of both
biosynthetic and endosomal cargo to lysosomes [8,
16, 22]. Recruitment of Tom1 to the IL-1Rs complex
was tested by coimmunoprecipitation revealing that
Tom1 also binds IL-1Rs and therefore may have a role
in IL-1RI degradation (Figure 4C). For confirmation of
this, the cellular levels of Tom1 were knocked down
with siRNA against Tom1 (Figure 4D, upper panel) and
the distribution of internalized IL-1RI was monitored
after different intervals of IL-1b stimulation. In both
wild-type and Tollip-deficient cells, IL-1RI was found to
accumulate on LAMP1-positive vesicles, even after pro-
longed intervals of IL-1b stimulation, suggesting that
Tom1 is involved in IL-1RI degradation and that it acts
downstream of Tollip (Figure 4D, lower panels). Collec-
tively, our findings support a model whereby IL-1RI is
shuttled from Tollip to Tom1, which in turn recruits com-
ponents of the endosomal-degradation machinery, such
as Hrs (suggested by coimmunoprecipitation of Tom1
and Hrs; see Figure S8A) and or TSG101 [22], crucial
for multivesicular-body formation and ultimately lyso-
somal degradation [23, 24]. Such a model is consistent
with the observation that Tom1 abrogated Tollip’s inter-
action with the IL-1Rs (Figure 4C), with the report that
ubiquitin and Tollip bind in a mutually exclusive manner
to an overlapping region in the GAT domain of Tom1 [25,26], and that a Tom1 mutant (Tom1 DGAT) only binds
weakly to IL-1R (Figure S8B). Because Tom1 is a cyto-
plasmic protein that is recruited to endosomes [25, 27]
(See Figure S8C, showing partial localization to late en-
dosomes), regulated recruitment of Tom1 to Tollip and
IL-1R complexes may have an important role in control-
ling lysosomal targeting of IL-1RI. In summary, the
effects of Tollip depletion reported here most plausibly
reflect a function of this protein in endosomes. Nonethe-
less, because Tollip is also rapidly recruited to IL-1RI
complex after IL-1b stimulation [14], it cannot be ex-
cluded that the observed effects on IL-1R degradation
are partially a consequence of this earlier event.
Growing evidence indicates that the endocytic and
signaling machinery of a receptor are intimately linked
such that signaling events modify the endocytic machin-
ery, which in turn modulates signaling (reviewed in [28,
29]). Canonical endocytic adapters (defined as proteins
with domains for protein–protein or protein–lipid inter-
action and sites, lacking catalytic activity, for inducible
post-translational modifications) have been described
as the junction ring between signaling and endocytosis
[30]. On one side, they are involved in the assembly
and perhaps specificity of signalosomes, and on the
other side, they are necessary to select and sort recep-
tor cargo. It is therefore important to mention that Tollip-
deficient mice produce less TNFa and IL-6 after IL-1b
administration, despite the absence of obvious defects
in signaling pathways (i.e., IkB degradation, JNK, p38,
and ERK phosphorylation) in Tollip 2/2 MEFs [19].
Thus, it is tempting to speculate that the magnitude of
the IL-1b response is attenuated in Tollip-deficient
mice because of Tollip’s role as an endocytic adaptor.
Given the important interplay that exists between endo-
cytosis and signaling and the pivotal position of endo-
cytic adapters, it will now be pertinent to understand
how Tollip regulates this exchange, the modulation
of which may provide an effective means of regulating
IL-1b-triggered inflammation.
Supplemental Data
Supplemental Data include Experimental Procedures and eight fig-
ures and can be found with this article online at http://www.
current-biology.com/cgi/content/full/16/22/2265/DC1/.
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